De Novo Pharmaceuticals Announces Drug Discovery Collaboration With Genzyme

19-Jan-2006

De Novo Pharmaceuticals Ltd., a computationally-based drug discovery company focused on small molecule therapeutics, announced that it has entered into a drug discovery collaboration agreement with Genzyme whereby De Novo will apply its novel molecular structure generating technology to focus on a disease target of interest to Genzyme. Financial terms of the agreement were not disclosed.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance